Loading clinical trials...
Loading clinical trials...
An Open-Label, Multicenter, Historically-Controlled Study to Assess Safety and Efficacy of ELAD in Subjects With Acute Liver Failure (ALF)
Conditions
Interventions
ELAD
Locations
18
United States
Keck Hospital of USC
Los Angeles, California, United States
Georgetown University Hospital
Washington D.C., District of Columbia, United States
University of Miami Hospital
Miami, Florida, United States
Tampa General Hospital
Tampa, Florida, United States
Cleveland Clinic Floriday
Weston, Florida, United States
Piedmont Atlanta Hospital
Atlanta, Georgia, United States
Start Date
October 1, 2014
Primary Completion Date
September 1, 2015
Completion Date
September 1, 2018
Last Updated
February 12, 2019
NCT07329036
NCT06831643
NCT06872372
NCT06285253
NCT07276568
NCT01148550
Lead Sponsor
Vital Therapies, Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions